Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
- PMID: 19330027
- PMCID: PMC2748125
- DOI: 10.1038/ng.354
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
Abstract
Genome-wide association studies (GWAS) have identified seven breast cancer susceptibility loci, but these explain only a small fraction of the familial risk of the disease. Five of these loci were identified through a two-stage GWAS involving 390 familial cases and 364 controls in the first stage, and 3,990 cases and 3,916 controls in the second stage. To identify additional loci, we tested over 800 promising associations from this GWAS in a further two stages involving 37,012 cases and 40,069 controls from 33 studies in the CGEMS collaboration and Breast Cancer Association Consortium. We found strong evidence for additional susceptibility loci on 3p (rs4973768: per-allele OR = 1.11, 95% CI = 1.08-1.13, P = 4.1 x 10(-23)) and 17q (rs6504950: per-allele OR = 0.95, 95% CI = 0.92-0.97, P = 1.4 x 10(-8)). Potential causative genes include SLC4A7 and NEK10 on 3p and COX11 on 17q.
Figures
Similar articles
-
Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.Anticancer Res. 2012 Feb;32(2):475-82. Anticancer Res. 2012. PMID: 22287734
-
Evaluation of breast cancer susceptibility loci in Chinese women.Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2357-65. doi: 10.1158/1055-9965.EPI-10-0054. Epub 2010 Aug 10. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20699374 Free PMC article.
-
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.Breast Cancer Res. 2010;12(6):R110. doi: 10.1186/bcr2797. Epub 2010 Dec 31. Breast Cancer Res. 2010. PMID: 21194473 Free PMC article.
-
The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes.Oncologist. 2013;18(5):493-500. doi: 10.1634/theoncologist.2012-0419. Epub 2013 May 1. Oncologist. 2013. PMID: 23635555 Free PMC article.
-
Genetic predisposition to breast cancer.Cancer. 1992 Sep 15;70(6 Suppl):1747-54. doi: 10.1002/1097-0142(19920915)70:4+<1747::aid-cncr2820701616>3.0.co;2-e. Cancer. 1992. PMID: 1516030 Review.
Cited by
-
Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls.Hum Mol Genet. 2013 Jun 15;22(12):2539-50. doi: 10.1093/hmg/ddt089. Epub 2013 Mar 27. Hum Mol Genet. 2013. PMID: 23535825 Free PMC article.
-
A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility.Eur J Hum Genet. 2012 Jun;20(6):682-9. doi: 10.1038/ejhg.2011.273. Epub 2012 Jan 18. Eur J Hum Genet. 2012. PMID: 22258532 Free PMC article.
-
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.Hum Genet. 2013 May;132(5):523-36. doi: 10.1007/s00439-013-1269-4. Epub 2013 Jan 25. Hum Genet. 2013. PMID: 23354978 Free PMC article.
-
One thousand genomes imputation in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium aggressive prostate cancer genome-wide association study.Prostate. 2013 May;73(7):677-89. doi: 10.1002/pros.22608. Epub 2012 Dec 19. Prostate. 2013. PMID: 23255287 Free PMC article.
-
Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women.Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):635-44. doi: 10.1158/1055-9965.EPI-11-1042. Epub 2012 Feb 1. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22301832 Free PMC article.
References
-
- Stacey SN, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007;39:865–869. - PubMed
-
- Stacey SN, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008;40:703–706. - PubMed
Publication types
MeSH terms
Grants and funding
- 11021/CRUK_/Cancer Research UK/United Kingdom
- U01 CA69417/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- U01 CA069467/CA/NCI NIH HHS/United States
- R01 CA058860/CA/NCI NIH HHS/United States
- CA67262/CA/NCI NIH HHS/United States
- P50 CA116201/CA/NCI NIH HHS/United States
- R01 CA102740-01A2/CA/NCI NIH HHS/United States
- R01 CA102740/CA/NCI NIH HHS/United States
- U01 CA069417/CA/NCI NIH HHS/United States
- R01 CA050385/CA/NCI NIH HHS/United States
- U01 CA069638/CA/NCI NIH HHS/United States
- 5UO1CA098233/CA/NCI NIH HHS/United States
- 10124/CRUK_/Cancer Research UK/United Kingdom
- C490/A11021/CRUK_/Cancer Research UK/United Kingdom
- 2004NOV49/BCN_/Breast Cancer Now/United Kingdom
- P01 CA087969/CA/NCI NIH HHS/United States
- CA87969/CA/NCI NIH HHS/United States
- U01 CA069398/CA/NCI NIH HHS/United States
- K07 CA092044/CA/NCI NIH HHS/United States
- CA49449/CA/NCI NIH HHS/United States
- U01 CA067262/CA/NCI NIH HHS/United States
- R01 CA065725/CA/NCI NIH HHS/United States
- 19275/CRUK_/Cancer Research UK/United Kingdom
- UO1 CA69467/CA/NCI NIH HHS/United States
- U01 CA069631/CA/NCI NIH HHS/United States
- U01 CA69398/CA/NCI NIH HHS/United States
- U01 CA098233/CA/NCI NIH HHS/United States
- U01 CA69638/CA/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- C1287/A7497/CRUK_/Cancer Research UK/United Kingdom
- A10123/CRUK_/Cancer Research UK/United Kingdom
- U01 CA058860/CA/NCI NIH HHS/United States
- CA-92044/CA/NCI NIH HHS/United States
- CA-06-503/CA/NCI NIH HHS/United States
- 10118/CRUK_/Cancer Research UK/United Kingdom
- U01 CA69446/CA/NCI NIH HHS/United States
- U01 CA69631/CA/NCI NIH HHS/United States
- CA-95-011/CA/NCI NIH HHS/United States
- R01 CA122340/CA/NCI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- UO1 CA098710/CA/NCI NIH HHS/United States
- P30 CA062203/CA/NCI NIH HHS/United States
- CA50385/CA/NCI NIH HHS/United States
- 11022/CRUK_/Cancer Research UK/United Kingdom
- CA-58860/CA/NCI NIH HHS/United States
- U01 CA049449/CA/NCI NIH HHS/United States
- U01 CA069446/CA/NCI NIH HHS/United States
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- R01 CA104021-04/CA/NCI NIH HHS/United States
- U01 CA69467/CA/NCI NIH HHS/United States
- U01 CA098710/CA/NCI NIH HHS/United States
- C1287/A5260/CRUK_/Cancer Research UK/United Kingdom
- CA65725/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases